Moxifloxacin is an 8-methoxy fluoroquinolone - a subset of the quinolone class of antibiotics. Developed and marketed by Bayer HealthCare AG as Avelox, moxifloxacin was approved to treat several acute respiratory and uncomplicated skin and soft tissue infections. It is widely used in countries all around the world.